What is he best known for?
The fields of study he is best known for:
- Virus
- Internal medicine
- Disease
Virology, Virus, Outbreak, Ebola virus and Ebola Hemorrhagic Fever are his primary areas of study.
The study of Virology is intertwined with the study of Antibody in a number of ways.
His work on Mononegavirales and Bunyaviridae as part of his general Virus study is frequently connected to Coronavirus and Reassortment, thereby bridging the divide between different branches of science.
His biological study spans a wide range of topics, including Veterinary medicine, Hantavirus pulmonary syndrome, Case fatality rate and Transmission.
His research investigates the connection with Hantavirus pulmonary syndrome and areas like Deer mouse which intersect with concerns in Sin Nombre virus.
His studies deal with areas such as Serology and Antigen as well as Ebola Hemorrhagic Fever.
His most cited work include:
- A novel coronavirus associated with severe acute respiratory syndrome. (3159 citations)
- Characterization of a novel coronavirus associated with severe acute respiratory syndrome (2031 citations)
- Chloroquine is a potent inhibitor of SARS coronavirus infection and spread (964 citations)
What are the main themes of his work throughout his whole career to date?
Thomas G. Ksiazek focuses on Virology, Virus, Outbreak, Hantavirus and Hantavirus pulmonary syndrome.
In his research, Antigen is intimately related to Antibody, which falls under the overarching field of Virology.
His study on Titer is often connected to Coronavirus as part of broader study in Virus.
His Outbreak research is multidisciplinary, relying on both Transmission, Encephalitis, Epidemiology and Veterinary medicine.
The concepts of his Hantavirus study are interwoven with issues in Bunyaviridae, Disease reservoir and Peromyscus.
His research in Hantavirus pulmonary syndrome intersects with topics in Deer mouse and Internal medicine, Disease.
He most often published in these fields:
- Virology (77.65%)
- Virus (38.59%)
- Outbreak (32.71%)
What were the highlights of his more recent work (between 2009-2021)?
- Virology (77.65%)
- Virus (38.59%)
- Ebola virus (20.24%)
In recent papers he was focusing on the following fields of study:
Thomas G. Ksiazek mostly deals with Virology, Virus, Ebola virus, Outbreak and Immunology.
His Virology study combines topics in areas such as Cell culture and Antibody.
His study in Antigen extends to Virus with its themes.
The Ebola virus study combines topics in areas such as Neutralization and Rickettsia.
Thomas G. Ksiazek combines subjects such as Transmission, Epidemiology, Infection control and Veterinary medicine with his study of Outbreak.
He usually deals with Epidemiology and limits it to topics linked to Disease cluster and Zoonosis and Case-control study.
Between 2009 and 2021, his most popular works were:
- Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with Coronavirus Disease, United States. (240 citations)
- Seasonal Pulses of Marburg Virus Circulation in Juvenile Rousettus aegyptiacus Bats Coincide with Periods of Increased Risk of Human Infection (218 citations)
- Date palm sap linked to nipah virus outbreak in bangladesh, 2008 (129 citations)
In his most recent research, the most cited papers focused on:
- Virus
- Disease
- Internal medicine
His scientific interests lie mostly in Virology, Virus, Outbreak, Ebola virus and Ebolavirus.
The study incorporates disciplines such as Epitope, Antibody and Genome in addition to Virology.
Thomas G. Ksiazek integrates Virus with Coronavirus in his research.
His study looks at the intersection of Outbreak and topics like Epidemiology with Encephalitis.
In Ebola virus, Thomas G. Ksiazek works on issues like Antigen, which are connected to Neutralization and Neutralizing antibody.
His Ebola Hemorrhagic Fever study combines topics from a wide range of disciplines, such as Outbreak response and Bundibugyo ebolavirus.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
